Yüklüyor......
Checkpoint Inhibition in Hodgkin’s Lymphoma – Saving the Best for Last?
Hodgkin lymphoma (HL) is a unique disease entity characterized by low number of neoplastic tumor cells surrounded by an inflammatory microenvironment composed of dysfunctional immune cells. Recent molecular and genetic studies have revealed that upregulation of the immune checkpoint pathway programm...
Kaydedildi:
| Yayımlandı: | Oncology (Williston Park) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6759920/ https://ncbi.nlm.nih.gov/pubmed/27753058 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|